References of "Bruyère, Olivier"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailTrends in hip fracture incidence and in the prescription of anti-osteoporosis medications during same time period in Belgium (2000-2007)
Hiligsmann, Mickaël ULg; Bruyère, Olivier ULg; Roberfroid, Dominique et al

in Arthritis Care & Research (2012), 64(5), 744-750

Detailed reference viewed: 38 (19 ULg)
Full Text
See detailÉtude des liens entre facteurs de croissance, consommation de lait et de produits laitiers et cancers
Boutron-Ruault, Marie-Christine; Bruyère, Olivier ULg; Charriere, Sybil et al

Report (2012)

Detailed reference viewed: 36 (4 ULg)
Full Text
Peer Reviewed
See detailHealth claims assessment in the field of joint and cartilage: a consensus viewpoint of the Group for the Respect of Ethics and Excellence in Science
Bruyère, Olivier ULg; Avouac, Bernard; Richette, Pascal et al

in Current Medical Research & Opinion (2012), 28(4), 611-6

Abstract Introduction: In 2006, the European Parliament and Council issued a regulation (No. 1924/2006) for the nutrition and health claims made on foods, including food supplements. According to the ... [more ▼]

Abstract Introduction: In 2006, the European Parliament and Council issued a regulation (No. 1924/2006) for the nutrition and health claims made on foods, including food supplements. According to the regulation, the use of nutrition and health claims shall only be permitted if the substance in respect of which the claim is made has been shown to have a beneficial nutritional or physiological effect. In the field of joint and cartilage health, there is no clear scientific-based definition of the nature of such a beneficial nutritional or physiological effect. The objective of this paper is to scientifically define the possible content of health claims related to joint and cartilage health and to provide scientific guidelines for the design of clinical studies which need to be adopted to substantiate such health claims. Methods: Literature review up to September 2011 followed by a consensus expert discussion organized by the Group for the Respect of Ethics and Excellence in Science (GREES). Results: In line with the general principles of the PASSCLAIM and the Codex recommendations, the GREES identified four acceptable health claims related to joint and cartilage health based on the effects on discomfort, joint and cartilage structural integrity or risk factors for joint and cartilage diseases. The GREES considers that randomized controlled trials on a relevant outcome is the best design to assess health claims. Moreover, animal studies could also be of interest to substantiate some health claims, to assess the clinical relevance of endpoints used in human studies or to extrapolate data obtained in patients to the target (apparently) healthy population. Conclusion: According to the methodology and biomarkers used in the study and whether or not additional animal studies are provided to support the claim, various health claims can be acceptable in the field of joint and cartilage health. [less ▲]

Detailed reference viewed: 22 (6 ULg)
See detailMensonge et vérité sur la vibrotonie
Bruyère, Olivier ULg

Scientific conference (2012, March 27)

Detailed reference viewed: 29 (5 ULg)
See detailAntidepressant use and fracture risk: a meta-analysis
Bruyère, Olivier ULg

Conference (2012, March 24)

Detailed reference viewed: 19 (1 ULg)
See detailHealth claims for nutriceuticals products in the field of cartilage and joint
Bruyère, Olivier ULg

Conference (2012, March 23)

Detailed reference viewed: 5 (0 ULg)
See detailNovel perspectives in the definition of responders in trials of osteoarthritis
Bruyère, Olivier ULg

Conference (2012, March 23)

Detailed reference viewed: 14 (0 ULg)
See detailHow to define responders in osteoarthritis?
Bruyère, Olivier ULg

Conference (2012, March 23)

Detailed reference viewed: 13 (0 ULg)
Full Text
Peer Reviewed
See detailSeverity of incident vertebral fracture and future fracture risk: a 3-year prospective study
Bruyère, Olivier ULg; Roux, Christian; Nicolet, Delphine ULg et al

in Osteoporosis International (2012, March), 23(Suppl. 2), 60-61

Detailed reference viewed: 27 (9 ULg)
Full Text
Peer Reviewed
See detailPerception, knowledge and use by general practitioners of Belgium of the FRAX tool
Bruyère, Olivier ULg; Nicolet, Delphine ULg; Compère, Stéphanie et al

in Osteoporosis International (2012, March), 23(Suppl. 2), 363-364

Detailed reference viewed: 14 (3 ULg)
Full Text
Peer Reviewed
See detailEffect of collagen hydrolysate in articular pain: A 6-month randomized, double-blind, placebo controlled study
Bruyère, Olivier ULg; Zegels, Brigitte ULg; LEONORI, Lorenzo ULg et al

in Osteoporosis International (2012, March), 23(Suppl. 2), 362-363

Detailed reference viewed: 42 (8 ULg)
Full Text
Peer Reviewed
See detailSevere prevalent vertebral fractures predict subsequent vertebral and nonvertebral fractures: a 3-year prospective study
Bruyère, Olivier ULg; Roux, Christian; Nicolet, Delphine ULg et al

in Osteoporosis International (2012, March), 23(Suppl. 2), 361-362

Detailed reference viewed: 17 (5 ULg)
Full Text
Peer Reviewed
See detailAssessment of joint space narrowing in knee osteoarthritis has good long-term intercentre reproducibility when read in pairs with a semi-automated device
Gensburger, Deborah; DEROISY, Rita ULg; Arlot, Monique et al

in Osteoporosis International (2012, March), 23(Suppl. 2), 247-248

Detailed reference viewed: 21 (6 ULg)
Full Text
Peer Reviewed
See detailRadiological and clinical profil of osteoarthritic patients undergoing of total joint replacement
Neuprez, Audrey ULg; François, Garance ULg; Bruyère, Olivier ULg et al

in Osteoporosis International (2012, March), 23(Suppl. 2), 129-130

Detailed reference viewed: 26 (8 ULg)
Full Text
Peer Reviewed
See detailLong-term (3 years) reproducibility for the radiological assessment of knee osteoarthritis
DEROISY, Rita ULg; Bruyère, Olivier ULg; Gensburger, Deborah et al

in Osteoporosis International (2012, March), 23(Suppl. 2), 219-220

Detailed reference viewed: 14 (3 ULg)
Full Text
Peer Reviewed
See detailAn economic evaluation of strontium ranelate for the treatment of male osteoporosis
Hiligsmann, Mickaël ULg; Ben Sedrine, Wafa ULg; Bruyère, Olivier ULg et al

in Osteoporosis International (2012, March), 23(Suppl. 2), 305-306

Detailed reference viewed: 26 (4 ULg)